Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation

Head and Neck Pathology

Volumn 2, Issue 1, 2008, Pages 1-12

  Kurago, Zoya B ^a   Lam ubol, Aroonwan ^b   Stetsenko, Anton ^b   De La Mater, Chris ^b   Chen, Yiyi ^c   Dawson, Deborah V ^b,c  

^a NEW YORK UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Cytokines; Inflammation; Interleukin 6; Lipopolysaccharide; Monocytes macrophages; Oral squamous cell carcinoma; STAT3; Toll like receptor; Vascular endothelial growth factor

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CARCINOMA IN SITU; COCULTURE; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; KERATINOCYTE; MACROPHAGE; METABOLISM; MONOCYTE; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; KERATINOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955236679     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-007-0038-x     Document Type: Article

References (46)

1. Sakamoto H, Naito H, Ohta Y, Tanakna R, Maeda N, Sasaki J, Nord CE. Isolation of bacteria from cervical lymph nodes in patients with oral cancer. Arch Oral Biol 1999;44:789-93.
2. Hooper ST, St J Crean, MAO Lewis, DA Spratt, WG Wade, MJ Wilson. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol 2006;1719-25.
3. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
4. Jecker P, Vogl K, Tietze L, Westhofen M. Dendritic cells, T-and B-lymphocytes and macrophages in supraglottic and glottic squamous epithelial carcinoma. Location and correlation with prognosis of the illness. Hno 1999;47:466-71.
5. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004;101:2779-87.
6. Vanbervliet B, Homey B, Durand I, Massacrier C, Ait-Yahia S, de Bouteiller O, Vicari A, Caux C. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 2002;32:231-42.
7. Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001;93:781-85.
8. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
9. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 2001;91:2136-47.
10. Macarthur M, Hold GL, El-Omar EM Inflammation, Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Review. Amer J Physiol--Gastroint & Liver Physiol 2004;286:G515-20.
11. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999;5:1369-79.
12. Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 2002;51:293-8.
13. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 2003;103:642-6.
14. Wang XP, Schunck M, Kallen KJ, Neumann C, Trautwein C, Rose-John S, Proksch E. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 2004;123:124-31.
15. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res 2003;63:2948-56.
16. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Review. Oncogene 2000;19(21):2548-56, 2000 May 15 19:2548-56.
17. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003;197:157-68.
18. Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N, Mantovani A, Lazzarin A, Sozzani S, Poli G. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998;91:258-65.
19. Maritano D, Sugrue ML, Tininini S, Dewilde S, Strobl B, Fu X, Murray-Tait V, Chiarle R, Poli V. The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol 2004;5:401-9.
20. Nagabhushanam V, Solache A, Ting LM, Escaron CJ, Zhang JY, Ernst JD. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFNgamma. J Immunol 2003;171:4750-7.
21. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 2004;10:48-54.
22. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY. Interleukin-6 promotes cervical tumor growth by VEGFdependent angiogenesis via a STAT3 pathway. Oncogene 2003;22(10):1517-27.
23. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002;21:2000-8.
24. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factorinduced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-4.
25. Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998;92:4150-66.
26. Kurago ZB, Lutz CT, Smith KD, Colonna M. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR + NK cells by HLAB7 variants and target cells. J Immunol 1998;160:1573-80.
27. Lutz CT, Kurago ZB. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Cancer Res 1999;59:5793-99.
28. Conover W. Practical nonparametric statistics. 3rd ed. New York: Wiley; 1999.
29. Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 1998;124:641-6.
30. Kikuchi K, Kusama K, Taguchi K, Ishikawa F, Okamoto M, Shimada J, Sakashita H, Yamamo Y. Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 2002;22:545-57.
31. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Review. Nat Rev Immunol 2004;4(12):941-52.
32. Wertz PW, Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Review. Crit Rev Ther Drug Carrier Syst 1991;8:237-69.
33. Mager DL HA, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Trans Res 2005;3:27.
34. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer.[see comment]. N Engl J Med 2001;345:784-9.
35. Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol 2002;10:293-9.
36. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Review. Nat Rev Cancer 2004;4(9):688-94.
37. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amano Y, Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004;173:1406-16.
38. Kojima M, Morisaki T, Izuhara K, Uchiyama A, Matsunari Y, Katano M, Tanaka M. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 2000;19:1225-31.
39. Wang JH, Manning BJ, Wu QD, Blankson S, Bouchier-Hayes D, Redmond HP. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J Immunol 2003;170:795-804.
40. Huang B, Zhao J, Li H, He KL, Chen Y, Mayer L, Unkeless JC, Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005;65:5009-14.
41. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC. Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 2002;119:424-32.
42. Lissoni P, Vigore L, Ferranti R, Bukovec R, Meregalli S, Mandala M, Barni S, Tancini G, Fumagalli L, Giani L. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease. J Biol Regul Homeost Agents 1999;13:216-9.
43. Hess S, Smola H, Sandaradura De Silva U, Hadaschik D, Kube D, Baldus SE, Flucke U, Pfister H. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol 2000;165:1939-48.
44. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE, Jr. Stat3 as an oncogene. Cell 1999;98(3):295-303; 1999 Aug 6 98:295-303. [Erratum appears in Cell 1999 Oct 15;99(2):239].
45. Xi S, Gooding WE, Grandis JR. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 2005;24:970-79.
46. Roland NJ, Casin AW, Nash J, Stell PM. Value of grading squamous cell carcinoma of the head and neck. Head & Neck 1992;14:224-29.